Active substanceBendazoleBendazole
Similar drugsTo uncover
  • Bendazole
    solution w / m in / in 
  • Dibasol
    solution w / m in / in 
    ATOLL, LLC     Russia
  • Dibasol
    solution w / m in / in 
  • Dibasol
    solution w / m in / in 
  • Dibasol
    solution w / m in / in 
    DALHIMFARM, OJSC     Russia
  • Dibasol
    solution w / m in / in 
  • Dibasol
    solution w / m in / in 
    VELFARM, LLC     Republic of San Marino
  • Dibazol-Vial
    solution w / m in / in 
    VIAL, LLC     Russia
  • Dibazol-Darnitsa
    solution w / m in / in 
  • Dibasol-UBF
    pills inwards 
    URALBIOFARM, OJSC     Russia
  • Dibazole tablets 0.02 g
    pills inwards 
    TsNKB FSUE     Russia
  • Dosage form: & nbspsolution for intravenous and intramuscular administration
    Composition:

    1 ml of the solution contains: active substance - Bendazole hydrochloride - 10 mg; Excipients: glycerol, ethanol 96%. hydrochloric acid in the form of 0.1 M solution, water for injection.

    Description:Transparent colorless liquid with a specific odor.
    Pharmacotherapeutic group:vasodilating agent.
    ATX: & nbsp

    C.04.A.X   Other peripheral vasodilators

    Pharmacodynamics:

    Spasmolytic agent of myotropic action. Has spasmolytic effect on smooth muscles of blood vessels and internal organs, dilates blood vessels.Reduces blood pressure by reducing cardiac output and expanding peripheral vessels. Hypotensive activity is very moderate, and the effect is short-lived.

    With intramuscular injection, the antihypertensive effect occurs within 30-60 minutes, and with intravenous administration for 15-20 minutes. The duration of the action is 2-3 hours.

    Indications:

    Hypertensive crisis, spasms of smooth muscles of internal organs (stomach ulcer, spasms of the pylorus and intestines).

    Contraindications:

    Hypersensitivity to the drug;

    The drug is contraindicated in diseases that are accompanied by increased muscle tone or convulsive syndrome.

    Pregnancy and lactation:

    As there is no data on the safety of the drug Dibazol-Vial for the fetus, it can not be used during pregnancy. During lactation, the issue of stopping breastfeeding during the treatment with Dibazol-Vial should be addressed.

    Dosing and Administration:

    Enter intravenously and intramuscularly.

    When hypertensive crisis is administered intravenously or intramuscularly 30-40 mg (3-4 ml of 10 mg / ml solution).

    With spasms of smooth muscles, the drug is administered in a dose of 10-20 mg (1-2 ml of a 10 mg / ml solution) intramuscularly.

    Simultaneously with the drug Dibazol-Vial, you can also use other antihypertensive drugs.

    Side effects:

    When used in large doses - a feeling of heat, increased sweating, dizziness, nausea, headache. When the dose is lowered or the drug is withdrawn, these side effects quickly disappear.

    Allergic reactions are possible.

    Interaction:

    Bendazole prevents beta-adrenergic blockers caused by an increase in total peripheral vascular resistance. With the simultaneous use of bendazole and phentolamine, the hypotensive effect of bendazole is enhanced. Bendazole enhances the antihypertensive effect of antihypertensive and diuretic drugs.

    Effect on the ability to drive transp. cf. and fur:

    Impacts on the ability to drive a car and work with technology does not have.

    Form release / dosage:

    Solution for intravenous and intramuscular injection 10 mg / ml.

    Packaging:1 or 5 ml of the drug in a vial of dark glass with a break point. 10 ampoules are placed in a contour mesh package.On 1 contour squamut in a cardboard pack together with the instruction on application.
    Storage conditions:

    Store in a dark place at a temperature of 5 to 30 ° C.

    Keep out of the reach of children.

    Shelf life:

    3 years.

    Do not use after the expiration date.

    Terms of leave from pharmacies:On prescription
    Registration number:LSR-006255/10
    Date of registration:01.07.2010
    The owner of the registration certificate:VIAL, LLC VIAL, LLC Russia
    Manufacturer: & nbsp
    Information update date: & nbsp18.07.2014
    Illustrated instructions
      Instructions
      Up